Uso de ileostomía derivativa en cáncer de ovario. Revisión de la literatura
DOI:
https://doi.org/10.30944/20117582.2469Palabras clave:
ileostomía, neoplasias ováricas, anastomosis quirúrgica, dehiscencia de la herida operatoria, fuga anastomóticaResumen
Introducción. La ileostomía derivativa de protección se realiza con el objetivo de proteger la anastomosis intestinal después de una resección colorrectal. Esta resección intestinal es el procedimiento extendido más frecuentemente realizado en pacientes con cáncer de ovario, con el fin de lograr una citorreducción completa. Conocer las indicaciones, el uso, las técnicas y las complicaciones de las ileostomías es importante para los grupos multidisciplinarios que tratan estas pacientes.
Métodos. Se realizó una búsqueda en PubMed vía Medline y una revisión narrativa actualizada de los principales hallazgos sobre las indicaciones, las técnicas quirúrgicas, complicaciones y el uso de la ileostomía derivativa en el cáncer de ovario.
Resultados. El uso de la ileostomía derivativa en cáncer de ovario sigue siendo un tema controvertido. Hasta la fecha, ni la ileostomía de derivación ni la ileostomía fantasma se han asociado con una reducción en la incidencia de la fuga anastomótica, pero ambas técnicas podrían disminuir su gravedad.
Conclusión. La ileostomía de derivación en cáncer de ovario se usa para proteger una anastomosis distal tras una resección intestinal, en caso de fuga anastomótica si no se ha realizado una ostomía previa o en caso de obstrucción intestinal.
Descargas
Referencias bibliográficas
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49. https://doi.org/10.3322/caac.21660
Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE III, et al. Worldwide burden, risk factors, and temporal trends of ovarian cancer: A global study. Cancers. 2022;14:e2230. https://doi.org/10.3390/cancers14092230
World Health Organization. International Agency for Research on Cancer. Global Cancer Observatory. Fecha de consulta: 2 de mayo de 2023. Disponible en: https://gco.iarc.fr/today/online-analysis-table?-v=2020&mode=cancer&mode_population=continents&population=900&populations=170&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%-5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=0&include_nmsc_other=1#collapse-group-0-1.
Heintz A, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the Fallopian tube. Int J Gynaecol Obstet. 2006;95(Suppl 1):145-60. https://doi.org/10.1016/S0020-7292(06)60032-5
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34. https://doi.org/10.3322/caac.21551
Ataseven B, Grimm C, Harter P, Heitz F, Traut A, Prader S, et al. Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV. Gynecol Oncol. 2016;140:215-20. https://doi.org/10.1016/j.ygyno.2015.12.007
Briceño-Morales C, Guerrero-Macías S, González F, Puerto AP, Burgos-Sáncez R, Millán-Matta C, et al. Tumores anexiales incidentales en cirugía abdominal. Rev Colomb Cir. 2022;37:129-34. https://doi.org/10.30944/20117582.1685
Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248-59. https://doi.org/10.1200/JCO.2002.20.5.1248
Hoskins WJ, Bundy BN, Thigpen JT, Omura GA. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 1992;47:159-66. https://doi.org/10.1016/0090-8258(92)90100-W.
Chi DS, Zivanovic O, Levinson KL, Kolev V, Huh J, Dottino J, et al. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol. 2010;119:38-42. https://doi.org/10.1016/j.ygyno.2010.05.031
Wright JD, Lewin SN, Deutsch I, Burke WM, Sun X, Neugut AI, et al. Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2011;123:467-73. https://doi.org/10.1016/j.ygyno.2011.08.027
Jones NL, Chen L, Chatterjee S, Tergas AI, Burke WM, Hou JY, et al. National Trends in Extended Procedures for Ovarian Cancer Debulking Surgery. Int J Gynecol Cancer. 2018;28:19-25. http://dx.doi.org/10.1097/IGC.0000000000001132
Lago V, Fotopoulou C, Chiantera V, Minig L, Gil-Moreno A, Cascales-Campos PA, et al. Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction. Gynecol Oncol. 2020;158:603-7. https://doi.org/10.1016/j.ygyno.2020.05.047
Richardson DL, Mariani A, Cliby WA. Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol. 2006;103:667-72. https://doi.org/10.1016/j.ygyno.2006.05.003
Kalogera E, Dowdy SC, Mariani A, Weaver AL, Aletti G, Bakkum-Gamez JN, et al. Multiple large bowel resections: potential risk factor for anastomotic leak. Gynecol Oncol. 2013;130:213-8. https://doi.org/10.1016/j.ygyno.2013.04.002
Tseng JH, Suidan RS, Zivanovic O, Gardner GJ, Sonoda Y, Levine DA, et al. Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes. Gynecol Oncol. 2016;142:217-24. https://doi.org/10.1016/j.ygyno.2016.05.035
Chi DS, Zivanovic O, Levinson KL, Kolev V, Huh J, Dottino J, et al. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol. 2010;119:38-42. https://doi.org/10.1016/j.ygyno.2010.05.031
Tsikitis VL, Larson DW, Poola VP, Nelson H, Wolff BG, Pemberton JH, et al. Postoperative morbidity with diversion after low anterior resection in the era of neoadjuvant therapy: a single institution experience. J Am Coll Surg. 2009;209:114-8. https://doi.org/10.1016/j.jamcollsurg.2009.03.020
Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD. Postoperative complications following surgery for rectal cancer. Ann Surg. 2010;251:807-18. https://doi.org/10.1097/SLA.0b013e3181dae4ed
Bartl T, Schwameis R, Stift A, Bachleitner-Hofmann T, Reinthaller A, Grimm C, et al. Predictive and prognostic implication of bowel resections during primary cytoreductive surgery in advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2018;28:1664-71. http://dx.doi.org/10.1097/IGC.0000000000001369
Grimm C, Harter P, Alesina PF, Prader S, Schneider S, Ataseven B, et al. The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery. Gynecol Oncol. 2017;146:498- 503. https://doi.org/10.1016/j.ygyno.2017.06.007
Lago V, Fotopoulou C, Chiantera V, Minig L, Gil-Moreno A, Cascales-Campos PA, et al. Risk factors for anastomotic leakage after colorectal resection in ovarian cancer surgery: A multi-centre study. Gynecol Oncol. 2019;153:549-54. https://doi.org/10.1016/j.ygyno.2019.03.241
Lago V, Flor B, Matute L, Padilla-Iserte P, García-Granero A, Bustamante M, et al. Ghost ileostomy in advanced ovarian cancer: A reliable option. Int J Gynecol Cancer. 2018;28:1418-26. http://dx.doi.org/10.1097/IGC.0000000000001299
Montedori A, Cirocchi R, Farinella E, Sciannameo F, Abraha I. Covering ileo- or colostomy in anterior resection for rectal carcinoma. Cochrane Database Syst Rev. 2010;12:CD006878. https://doi.org/10.1002/14651858.CD006878.pub2
Glasgow MA, Shields K, Vogel RI, Teoh D, Argenta PA. Postoperative readmissions following ileostomy formation among patients with a gynecologic malignancy. Gynecol Oncol. 2014;134:561-5. https://doi.org/10.1016/j.ygyno.2014.06.005
Phatak UR, Kao LS, You YN, Rodriguez-Bigas MA, Skibber JM, Feig BW, et al. Impact of ileostomy-related complications on the multidisciplinary treatment of rectal cancer. Ann Surg Oncol. 2014;21:507-12. https://doi.org/10.1245/s10434-013-3287-9
Vonk-Klaassen SM, de Vocht HM, den Ouden ME, Eddes EH, Schuurmans MJ. Ostomy-related problems and their impact on quality of life of colorectal cancer ostomates: a systematic review. Qual Life Res. 2016;25:125- 33. https://doi.org/10.1007/s11136-015-1050-3
Kalogera E, Nitschmann CC, Dowdy SC, Cliby WA, Langstraat CL. A prospective algorithm to reduce anastomotic leaks after rectosigmoid resection for gynecologic malignancies. Gynecol Oncol. 2017;144:343-7. https://doi.org/10.1016/j.ygyno.2016.11.032
Raimes SA, Mathew VV, Devlin HB. Temporary loop ileostomy. J R Soc Med. 1984;77:738-41. https://doi.org/10.1177/014107688407700905
Miccini M, Amore-Bonapasta S, Gregori M, Barillari P, Tocchi A. Ghost ileostomy: Real and potential advantages. Am J Surg. 2010;200:e55-7. https://doi.org/10.1016/j.amjsurg.2009.12.017
Lago V, Domingo S, Matute L, Padilla P, Flor B, GarcíaGranero Á. Ghost ileostomy in advanced ovarian cancer. Gynecol Oncol. 2017;147:488. https://doi.org/10.1016/j.ygyno.2017.08.017
Lago V, Sala Climent L, Segarra-Vidal B, Frasson M, Flor B, Domingo S. Ghost ileostomy: prevention, diagnosis, and early treatment of colorectal anastomosis leakage in advanced ovarian cancer. Int J Gynecol Cancer. 2022;32:109-10. http://dx.doi.org/10.1136/ijgc-2021-003060
Mori L, Vita M, Razzetta F, Meinero P, D’Ambrosio G. Ghost ileostomy in anterior resection for rectal carcinoma: is it worthwhile? Dis Colon Rectum. 2013;56:29- 34. https://doi.org/10.1097/DCR.0b013e3182716ca1
Lago V, Fotopoulou C, Chiantera V, Minig L, Gil-Moreno A, Cascales-Campos PA, et al. Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction. Gynecol Oncol. 2020;158:603-7. https://doi.org/10.1016/j.ygyno.2020.05.047
Messaris E, Sehgal R, Deiling S, Koltun WA, Stewart D, McKenna K., et al. Dehydration is the most common indication for readmission after diverting ileostomy creation. Dis Colon Rectum. 2012;55:175-80. https://doi.org/10.1097/DCR.0b013e31823d0ec5.
Paquette IM, Solan P, Rafferty JF, Ferguson MA, Davis BR. Readmission for dehydration or renal failure after ileostomy creation. Dis Colon Rectum. 2013;56:974-9. https://doi.org/10.1097/DCR.0b013e31828d02ba
Yang YW, Huang SC, Cheng HH, Chang SC, Jiang JK, Wang HS, et al. Protective loop ileostomy or colostomy? a risk evaluation of all common complications. Ann Coloproctol. 2023;ac.2022.00710.0101. https://doi.org/10.3393/ac.2022.00710.0101
Kariv Y, Wang W, Senagore AJ, Hammel JP, Fazio VW, Delaney CP. Multivariable analysis of factors associated with hospital readmission after intestinal surgery. Am J Surg. 2006;191:364-71. https://doi.org/10.1016/j.amjsurg.2005.10.038
Courtney ED, Ankrett S, McCollum PT. 28-Day emergency surgical re-admission rates as a clinical indicator of performance. Ann R Coll Surg Engl. 2003;85:75-8. https://doi.org/10.1308/003588403321219803
Koscielny A, Ko A, Egger EK, Kuhn W, Kalff JC, KeyverPaik MD. Prevention of anastomotic leakage in ovarian cancer debulking surgery and its impact on overall survival. Anticancer Res. 2019;39:5209-18. https://doi.org/10.21873/anticanres.13718
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Revista Colombiana de Cirugía
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Todos los textos incluidos en la Revista Colombiana de Cirugía están protegidos por derechos de autor. Las opiniones expresadas en los artículos firmados son las de los autores y no coinciden necesariamente con las de los directores o los editores de la Revista Colombiana de Cirugía. Las sugerencias diagnósticas o terapéuticas como elección de productos, dosificación y métodos de empleo corresponden a la experiencia y al criterio de los autores.
.jpg)
